Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	495.15	519.85	615.1	905.45	1,431	1,895
Short-Term Investments	-	6.14	13.41	2.09	65.63	367.39
Cash & Short-Term Investments	495.15	525.99	628.5	907.55	1,497	2,263
Cash Growth	-13.53%	-16.31%	-30.75%	-39.37%	-33.84%	450.69%
Accounts Receivable	176.64	165.87	149.61	151.71	134.59	110.75
Other Receivables	-	0.18	1.18	0.1	0.11	2.23
Receivables	176.64	166.05	150.79	151.81	138.2	112.98
Inventory	65.42	62.63	69.02	130.32	123.21	68.02
Restricted Cash	2.26	2.31	0.12	19.82	7.8	29.9
Other Current Assets	22.07	19.65	35.67	49.27	54.79	50.06
Total Current Assets	761.54	776.62	884.1	1,259	1,821	2,524
Property, Plant & Equipment	84.97	100.34	144.2	300.03	406.45	111.48
Long-Term Investments	-	-	0.34	0.69	0.91	1.42
Other Intangible Assets	0.39	0.42	0.96	1.99	5.15	3.46
Other Long-Term Assets	7.82	7.93	5.09	20.89	45.14	23.02
Total Assets	854.72	885.31	1,040	1,587	2,279	2,663
Accounts Payable	35.94	33.75	18.06	50.95	63.08	35.48
Accrued Expenses	76.2	56.94	65.37	104.23	107.03	71.89
Short-Term Debt	-	-	-	-	2.37	7.37
Current Portion of Long-Term Debt	-	-	-	-	-	34.7
Current Portion of Leases	22.52	24.57	8.63	37.24	35	4.82
Current Income Taxes Payable	-	14.46	20.62	11.03	7.69	6.99
Current Unearned Revenue	117.2	117.9	130.54	147.63	142.87	74.4
Other Current Liabilities	0.59	18.69	20.14	60.38	14.14	5.89
Total Current Liabilities	252.45	266.3	263.36	411.45	372.18	241.53
Long-Term Leases	19.81	27.75	3.69	13.55	49.32	-
Long-Term Unearned Revenue	-	-	-	-	-	0.26
Other Long-Term Liabilities	10.65	10.43	4.54	4.12	11.78	0.23
Total Liabilities	282.92	304.48	271.59	429.13	433.28	242.02
Common Stock	0.15	0.15	0.14	0.14	0.14	0.14
Additional Paid-In Capital	5,006	5,002	4,849	4,583	4,281	4,007
Retained Earnings	-4,214	-4,200	-3,854	-3,200	-2,229	-1,418
Treasury Stock	-62.45	-63.26	-65.9	-58.92	-	-
Comprehensive Income & Other	-158.12	-158.05	-161.53	-165.72	-207.07	-167.59
Total Common Equity	571.8	580.83	768.41	1,158	1,845	2,421
Shareholders' Equity	571.8	580.83	768.41	1,158	1,845	2,421
Total Liabilities & Equity	854.72	885.31	1,040	1,587	2,279	2,663
Total Debt	42.34	52.32	12.32	50.79	86.69	46.88
Net Cash (Debt)	452.81	473.66	616.18	856.76	1,410	2,216
Net Cash Growth	-18.21%	-23.13%	-28.08%	-39.25%	-36.35%	545.24%
Net Cash Per Share	43.45	46.02	60.18	82.45	135.33	322.84
Filing Date Shares Outstanding	10.76	10.77	10.26	10.27	10.52	10.45
Total Common Shares Outstanding	10.76	10.76	10.24	10.26	10.51	10.48
Working Capital	509.09	510.32	620.73	847.31	1,449	2,282
Book Value Per Share	53.13	53.97	75.01	112.85	175.56	231.05
Tangible Book Value	571.42	580.41	767.45	1,156	1,840	2,418
Tangible Book Value Per Share	53.10	53.93	74.92	112.66	175.07	230.72
Machinery	-	307.49	348.07	339.09	297.89	180.54
Construction In Progress	-	0.63	0.55	2.66	27.56	1.09
Leasehold Improvements	-	187.23	187.39	187.38	161.04	30.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q